Lyme disease and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): An overview

International Journal of General Medicine

Volumn 5, Issue , 2012, Pages 163-174

  Rhee, Hanna ^a   Cameron, Daniel J ^b  

^a Sharp Rees Stealy Medical Group   (United States)

^b Northern Westchester Hospital   (United States)

Author keywords

Borrelia burgdorferi; Infection; Neuroborreliosis; Obsessive compulsive disorder; Strep throat; Tic disorder

Indexed keywords

IMMUNOGLOBULIN; PLACEBO;

AMNESIA; BACTERIAL IMMUNITY; BACTERIUM DETECTION; BEHAVIOR CHANGE; BORRELIA BURGDORFERI; CLINICAL FEATURE; DISEASE COURSE; EATING DISORDER; GROUP A STREPTOCOCCAL INFECTION; HUMAN; LABORATORY TEST; LYME DISEASE; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PATHOGENESIS; PEDIATRIC NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCAL INFECTION; PLASMAPHERESIS; REVIEW; STREPTOCOCCUS PYOGENES; SYMPTOM ASSESSMENT;

EID: 84877156122     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S24212     Document Type: Review

References (168)

1. Committee on Lyme Disease and Other Tick-Borne Diseases: The State of the Science, Institute of Medicine. Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases: The Short-Term and Long-Term Answers; Workshop Report. Washington DC: National Academies Press; 2011.
2. Cameron DJ. Consequences of treatment delay in Lyme disease. J Eval Clin Pract. 2007;13(3):470-472.
3. Bacon RM, Kugeler KJ, Mead PS; for Centers for Disease Control and Prevention. Surveillance for Lyme disease: United States, 1992-2006. MMWR Surveill Summ. 2008;57(10):1-9.
4. Swanson SJ, Neitzel D, Reed KD, Belongia EA. Coinfections acquired from Ixodes ticks. Clin Microbiol Rev. 2006;19(4):708-727.
5. American Psychiatric Association, Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed. Washington DC: American Psychiatric Association; 1994.
6. Swedo SE, Grant PJ. Annotation: PANDAS; a model for human autoimmune disease. J Child Psychol Psychiatry. 2005;46(3): 227-234.
7. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155(2):264-271.
8. Danchin MH, Rogers S, Kelpie L, et al. Burden of acute sore throat and group A streptococcal pharyngitis in school-aged children and their families in Australia. Pediatrics. 2007;120(5):950-957.
9. Choby BA. Diagnosis and treatment of streptococcal pharyngitis. Am Fam Physician. 2009;79(5):383-390.
10. Swedo SE, Schrag A, Gilbert R, et al. Streptococcal infection, Tourette syndrome, and OCD: is there a connection? PANDAS: horse or zebra? Neurology. 2010;74(17):1397-1398; author reply 1398-1399.
11. Gilbert DL, Kurlan R. PANDAS: horse or zebra? Neurology. 2009; 73(16):1252-1253.
12. Packer LE. New research calls connection between strep infections and tics and obsessive-compulsive symptoms into question. The TS blog: the companion blog to Tourette syndrome "plus"; January 26, 2011. Available from: http://www.tsplusblog.com/2011/01/new-research-callsconnection-between-strep-infections-and-tics-and-obsessive-compulsivesymptoms-into-question/. Accessed September 16, 2011.
13. Barbour AG, Hayes SF. Biology of Borrelia species. Microbiol Rev. 1986;50(4):381-400.
14. Tilly K, Rosa PA, Stewart PE. Biology of infection with Borrelia burgdorferi. Infect Dis Clin North Am. 2008;22(2):217-234, v.
15. Anderson JF. Epizootiology of Borrelia in Ixodes tick vectors and reservoir hosts. Rev Infect Dis. 1989;11 Suppl 6:S1451-S1459.
16. Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 1977;20(1):7-17.
17. Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med. 1983;308(13):740-742.
18. Matuschka FR, Ohlenbusch A, Eiffert H, Richter D, Spielman A. Antiquity of the Lyme-disease spirochaete in Europe. Lancet. 1995; 346(8986):1367.
19. Matuschka FR, Ohlenbusch A, Eiffert H, Richter D, Spielman A. Characteristics of Lyme disease spirochetes in archived European ticks. J Infect Dis. 1996;174(2):424-426.
20. Schmid GP. The global distribution of Lyme disease. Rev Infect Dis. 1985;7(1):41-50.
21. Comstedt P, Bergstrom S, Olsen B, et al. Migratory passerine birds as reservoirs of Lyme borreliosis in Europe. Emerg Infect Dis. 2006;12(7): 1087-1095.
22. Sal MS, Li C, Motalab MA, Shibata S, Aizawa S, Charon NW. Borrelia burgdorferi uniquely regulates its motility genes and has an intricate flagellar hook-basal body structure. J Bacteriol. 2008;190(6): 1912-1921.
23. Miklossy J, Kasas S, Zurn AD, McCall S, Yu S, McGeer PL. Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation. 2008;5:40.
24. Hovius JW. Spitting image: tick saliva assists the causative agent of Lyme disease in evading host skin's innate immune response. J Invest Dermatol. 2009;129(10):2337-2339.
25. Diterich I, Rauter C, Kirschning CJ, Hartung T. Borrelia burgdorferiinduced tolerance as a model of persistence via immunosuppression. Infect Immun. 2003;71(7):3979-3987.
26. Steere AC, Drouin EE, Glickstein LJ. Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis. Clin Infect Dis. 2011;52 Suppl 3:S259-S265.
27. Coburn J, Fischer JR, Leong JM. Solving a sticky problem: new genetic approaches to host cell adhesion by the Lyme disease spirochete. Mol Microbiol. 2005;57(5):1182-1195.
28. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH; for Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis. 2002;35(2):113-125.
29. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13(3):470-511.
30. Eisenhut M. Food as source of outbreaks of group A streptococcal disease. Arch Dis Child. 2011;96(3):323.
31. Aguero J, Ortega-Mendi M, Eliecer Cano M, et al. Outbreak of invasive group A streptococcal disease among children attending a day-care center. Pediatr Infect Dis J. 2008;27(7):602-604.
32. Hayes CS, Williamson H Jr. Management of group A beta-hemolytic streptococcal pharyngitis. Am Fam Physician. 2001;63(8): 1557-1564.
33. Bisno AL. The resurgence of acute rheumatic fever in the United States. Annu Rev Med. 1990;41:319-329.
34. Erdem G, Mizumoto C, Esaki D, Abe L, Reddy V, Effler PV. Streptococcal emm types in Hawaii: a region with high incidence of acute rheumatic fever. Pediatr Infect Dis J. 2009;28(1):13-16.
35. de Koning J, Tazelaar DJ, Hoogkamp-Korstanje JA, Elema JD. Acrodermatitis chronica atrophicans: a light and electron microscopic study. J Cutan Pathol. 1995;22(1):23-32.
36. Girschick HJ, Huppertz HI, Rüssmann H, Krenn V, Karch H. Intracellular persistence of Borrelia burgdorferi in human synovial cells. Rheumatol Int. 1996;16(3):125-132.
37. Barthold SW, Hodzic E, Tunev S, Feng S. Antibody-mediated disease remission in the mouse model of lyme borreliosis. Infect Immun. 2006;74(8):4817-4825.
38. Berende A, Oosting M, Kullberg BJ, Netea MG, Joosten LA. Activation of innate host defense mechanisms by Borrelia. Eur Cytokine Netw. 2010;21(1):7-18.
39. Schröder NW, Eckert J, Stübs G, Schumann RR. Immune responses induced by spirochet al outer membrane lipoproteins and glycolipids. Immunobiology. 2008;213(3-4):329-340.
40. Ruderman EM, Kerr JS, Telford SR 3rd, Spielman A, Glimcher LH, Gravallese EM. Early murine Lyme carditis has a macrophage predominance and is independent of major histocompatibility complex class II-CD4ccT cell interactions. J Infect Dis. 1995;171(2):362-370.
41. Barthold SW, Beck DS, Hansen GM, Terwilliger GA, Moody KD. Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis. 1990;162(1):133-138.
42. DePietropaolo DL, Powers JH, Gill JM, Foy AJ. Diagnosis of Lyme disease. Am Fam Physician. 2005;72(2):297-304.
43. Smith RP, Schoen RT, Rahn DW, et al. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med. 2002;136(6):421-428.
44. Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T. Lyme borreliosis. Lancet Infect Dis. 2003;3(8):489-500.
45. Berger BW. Dermatologic manifestations of Lyme disease. Rev Infect Dis. 1989;11 Suppl 6:S1475-S1481.
46. Aucott J, Morrison C, Munoz B, Rowe PC, Schwarzwalder A, West SK. Diagnostic challenges of early Lyme disease: lessons from a community case series. BMC Infect Dis. 2009;9:79.
47. Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ. Treatment of late Lyme borreliosis-randomised comparison of ceftriaxone and penicillin. Lancet. 28 1988;1(8596):1191-1194.
48. Bhate C, Schwartz RA. Lyme disease Part I. Advances and perspectives. J Am Acad Dermatol. 2011;64(4):619-636.
49. Nowakowski J, McKenna D, Nadelman RB, et al. Failure of treatment with cephalexin for Lyme disease. Arch Fam Med. 2000;9(6): 563-567.
50. Steere AC, Bartenhagen NH, Craft JE, et al. The early clinical manifestations of Lyme disease. Ann Intern Med. 1983;99(1):76-82.
51. Centers for Disease Control and Prevention (CDC). Lyme disease (Borrelia burgdorferi): 2011 case definition. Alanta, GA: CDC; 2011 [updated August 5, 2011]. Available from: http://www.cdc.gov/osels/ ph_surveillance/nndss/casedef/lyme_disease_Current.htm. Accessed September 16, 2011.
52. Costello JM, Alexander ME, Greco KM, Perez-Atayde AR, Laussen PC. Lyme carditis in children: presentation, predictive factors, and clinical course. Pediatrics. 2009;123(5):e835-e841.
53. Davidson RS. Orthopaedic complications of Lyme disease in children. Biomed Pharmacother. 1989;43(6):405-408.
54. Tager FA, Fallon BA, Keilp J, Rissenberg M, Jones CR, Liebowitz MR. A controlled study of cognitive deficits in children with chronic Lyme disease. J Neuropsychiatry Clin Neurosci. 2001;13(4):500-507.
55. Chmelik E, Awadallah N, Hadi FS, Quinn K, Franco K. Varied presentation of PANDAS: a case series. Clin Pediatr (Phila). 2004; 43(4):379-382.
56. Fallon BA, Levin ES, Schweitzer PJ, Hardesty D. Inflammation and central nervous system Lyme disease. Neurobiol Dis. 2010;37(3): 534-541.
57. Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest. 2004;113(8):1093-1101.
58. Wang G, Ojaimi C, Wu H, et al. Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis. 2002;186(6): 782-791.
59. Weis JJ, McCracken BA, Ma Y, et al. Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease. J Immunol. 1999;162(2):948-956.
60. Pachner AR, Cadavid D, Shu G, et al. Central and peripheral nervous system infection, immunity, and inflammation in the NHP model of Lyme borreliosis. Ann Neurol. 2001;50(3):330-338.
61. García-Moncó JC, Fernández Villar B, Benach JL. Lyme borreliosis: neurologic manifestations. Neurologia. 1990;5(9):315-322. Spanish.
62. Coleman JL, Sellati TJ, Testa JE, Kew RR, Furie MB, Benach JL. Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers. Infect Immun. 1995;63(7):2478-2484.
63. Sellati TJ, Burns MJ, Ficazzola MA, Furie MB. Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro. Infect Immun. 1995;63(11):4439-4447.
64. Grab DJ, Perides G, Dumler JS, et al. Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier. Infect Immun. 2005;73(2): 1014-1022.
65. Phillips SE, Harris NS, Horowitz R, Johnson L, Stricker RB. Lyme disease: scratching the surface. Lancet. 2005;366(9499):1771.
66. Norman MU, Moriarty TJ, Dresser AR, Millen B, Kubes P, Chaconas G. Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host. PLoS Pathog. 2008;4(10): e1000169.
67. Moriarty TJ, Norman MU, Colarusso P, Bankhead T, Kubes P, Chaconas G. Real-time high resolution 3D imaging of the lyme disease spirochete adhering to and escaping from the vasculature of a living host. PLoS Pathog. 2008;4(6):e1000090.
68. Kandel ER, Schwartz JH, Jessell TM. Principles of Neural Science. 4th ed. New York, NY: McGraw-Hill, Health Professions Division; 2000.
69. Weis JJ, Ma Y, Erdile LF. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect Immun. 1994;62(10):4632-4636.
70. Cruz AR, Moore MW, La Vake CJ, Eggers CH, Salazar JC, Radolf JD. Phagocytosis of Borrelia burgdorferi, the Lyme disease spirochete, potentiates innate immune activation and induces apoptosis in human monocytes. Infect Immun. 2008;76(1):56-70.
71. Ramesh G, Borda JT, Dufour J, et al. Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis. Am J Pathol. 2008;173(5):1415-1427.
72. Ramesh G, Borda JT, Gill A, et al. Possible role of glial cells in the onset and progression of Lyme neuroborreliosis. J Neuroinflammation. 2009;6:23.
73. Myers TA, Kaushal D, Philipp MT. Microglia are mediators of Borrelia burgdorferi-induced apoptosis in SH-SY5Y neuronal cells. PLoS Pathog. 2009;5(11):e1000659.
74. Chandra A, Wormser GP, Klempner MS, et al. Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun. 2010;24(6):1018-1024.
75. Volkman D. Letter to the editor re "Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms" by Chandra et al. Brain Behav Immun. 2010;24(6):1027; author reply 1028.
76. Stricker RB, Johnson L. Letter to the editor re "Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms" by Chandra et al. Brain Behav Immun. 2010;24(6):1025; author reply 1026.
77. Newell MK, Tobin RP, Cabrera JH, et al. TLR-mediated B cell activation results in ectopic CLIP expression that promotes B cell-dependent inflammation. J Leukoc Biol. 2010;88(4):779-789.
78. Luft BJ, Steinman CR, Neimark HC, et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA. 1992;267(10):1364-1367.
79. Belman AL, Iyer M, Coyle PK, Dattwyler R. Neurologic manifestations in children with North American Lyme disease. Neurology. 1993;43(12):2609-2614.
80. Kieslich M, Fiedler A, Driever PH, Weis R, Schwabe D, Jacobi G. Lyme borreliosis mimicking central nervous system malignancy: the diagnostic pitfall of cerebrospinal fluid cytology. Brain Dev. 2000;22(6):403-406.
81. Bloom BJ, Wyckoff PM, Meissner HC, Steere AC. Neurocognitive abnormalities in children after classic manifestations of Lyme disease. Pediatr Infect Dis J. 1998;17(3):189-196.
82. Fallon BA, Kochevar JM, Gaito A, Nields JA. The underdiagnosis of neuropsychiatric Lyme disease in children and adults. Psychiatr Clin North Am. 1998;21(3):693-703, viii.
83. McAuliffe P, Brassard MR, Fallon B. Memory and executive functions in adolescents with posttreatment Lyme disease. Appl Neuropsychol. 2008;15(3):208-219.
84. Riedel M, Straube A, Schwarz MJ, Wilske B, Muller N. Lyme disease presenting as Tourette's syndrome. Lancet. 1998;351(9100):418-419.
85. Branson WP. A Clinical study on the avenues of rheumatic infection: based upon examination of 75 cases of Sydenham's chorea. Br Med J. 1912;2(2708):1429-1432.
86. Poynton FJ. Remarks on the infective nature of rheumatic fever, Illustrated by the study of a fatal case: read before the Medical Society of London, May 9th, 1904. Br Med J. 1904;1(2263):1117-1120.
87. Walker KG, Wilmshurst JM. An update on the treatment of Sydenham's chorea: the evidence for established and evolving interventions. Ther Adv Neurol Disord. 2010;3(5):301-309.
88. Yaddanapudi K, Hornig M, Serge R, et al. Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol Psychiatry. 2010;15(7):712-726.
89. Murphy TK, Storch EA, Turner A, Reid JM, Tan J, Lewin AB. Maternal history of autoimmune disease in children presenting with tics and/or obsessive-compulsive disorder. J Neuroimmunol. 2010;229(1-2):243-247.
90. Kirvan CA, Swedo SE, Snider LA, Cunningham MW. Antibodymediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol. 2006;179(1-2):173-179.
91. Bartholomäus I, Kawakami N, Odoardi F, et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature. 2009;462(7269):94-98.
92. Huerta PT, Kowal C, DeGiorgio LA, Volpe BT, Diamond B. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A. 2006;103(3):678-683.
93. Murphy TK, Kurlan R, Leckman J. The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol. 2010;20(4):317-331.
94. American Psychiatric Association. Diagnostic Criteria from DSMIV-TR. Washington DC: American Psychiatric Association; 2000.
95. American Psychiatric Association DSM-5 Development [home page on the Internet]. Arlington (VA): American Psychiatric Association; 2011. Available from: http://www.dsm5.org/Pages/Default.aspx. Accessed September 16, 2011.
96. Bernstein GA, Victor AM, Pipal AJ, Williams KA. Comparison of clinical characteristics of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and childhood obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2010;20(4):333-340.
97. Snider LA, Lougee L, Slattery M, Grant P, Swedo SE. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry. 2005;57(7):788-792.
98. Calkin CV, Carandang CG. Certain eating disorders may be a neuropsychiatric manifestation of PANDAS: case report. J Can Acad Child Adolesc Psychiatry. 2007;16(3):132-135.
99. Elia J, Dell ML, Friedman DF, et al. PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. J Am Acad Child Adolesc Psychiatry. 2005;44(11):1145-1150.
100. Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention (CDC). Lyme disease diagnosis. Atlanta (GA): CDC; 2010. Available from: http://www.cdc.gov/ncidod/dvbid/lyme/ ld_humandisease_diagnosis.htm. Accessed September 16, 2011.
101. Schutzer SE, Angel TE, Liu T, et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS One. 2011;6(2):e17287.
102. Tumani H, Cadavid D. Are high CSF levels of CXCL13 helpful for diagnosis of Lyme neuroborreliosis? Neurology. 2011;76(12): 1034-1035.
103. Tveitnes D, Oymar K, Natas O. Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms. Scand J Infect Dis. 2009;41(5):355-362.
104. McIsaac WJ, Goel V, To T, Low DE. The validity of a sore throat score in family practice. CMAJ. 2000;163(7):811-815.
105. Tanz RR, Gerber MA, Kabat W, Rippe J, Seshadri R, Shulman ST. Performance of a rapid antigen-detection test and throat culture in community pediatric offices: implications for management of pharyngitis. Pediatrics. 2009;123(2):437-444.
106. Hall MC, Kieke B, Gonzales R, Belongia EA. Spectrum bias of a rapid antigen detection test for group A beta-hemolytic streptococcal pharyngitis in a pediatric population. Pediatrics. 2004;114(1): 182-186.
107. Dranitzki Z, Steiner I. PANDAS in siblings: a common risk? Eur J Neurol. 2007;14(6):e4.
108. Church AJ, Dale RC. Antistreptolysin-O titers: implications for adult PANDAS; pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Am J Psychiatry. 2002;159(2):320.
109. Orvidas LJ, Slattery MJ. Pediatric autoimmune neuropsychiatric disorders and streptococcal infections: role of otolaryngologist. Laryngoscope. 2001;111(9):1515-1519.
110. Mink J, Kurlan R. Acute postinfectious movement and psychiatric disorders in children and adolescents. J Child Neurol. 2011;26(2): 214-217.
111. Kuluva J, Hirsch S, Coffey B. PANDAS and paroxysms: a case of conversion disorder? J Child Adolesc Psychopharmacol. 2008;18(1): 109-115.
112. Fusco FR, Pompa A, Bernardi G, et al. A case of PANDAS treated with tetrabenazine and tonsillectomy. J Child Neurol. 2010;25(5): 614-615.
113. Segarra AR, Murphy TK. Cardiac involvement in children with PANDAS. J Am Acad Child Adolesc Psychiatry. 2008;47(5): 603-604.
114. Bodner SM, Morshed SA, Peterson BS. The question of PANDAS in adults. Biol Psychiatry. 2001;49(9):807-810.
115. Bernardino AL, Kaushal D, Philipp MT. The antibiotics doxycycline and minocycline inhibit the inflammatory responses to the Lyme disease spirochete Borrelia burgdorferi. J Infect Dis. 2009; 199(9):1379-1388.
116. Cameron D, Gaito A, Harris N, et al. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther. 2004;2(1 Suppl):S1-S13.
117. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089-1134.
118. Johnson L. Lyme disease: two standards of care. Bethesda (MA): International Lyme and Associated Diseases Society; 2005 [updated Feb 2005]; Available from: http://www.ilads.org/lyme_research/ lyme_articles4.html. Accessed September 16, 2011.
119. Steere AC, Klitz W, Drouin EE, et al. Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J Exp Med. 2006;203(4):961-971.
120. Seward RJ, Drouin EE, Steere AC, Costello CE. Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis. Mol Cell Proteomics. 2011;10(3):M110.002477.
121. Wessels MR. Clinical practice: streptococcal pharyngitis. N Engl J Med. 2011;364(7):648-655.
122. Murphy ML, Pichichero ME. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med. 2002;156(4):356-361.
123. Garvey MA, Perlmutter SJ, Allen AJ, et al. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry. 1999;45(12):1564-1571.
124. Perlmutter SJ, Leitman SF, Garvey MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessivecompulsive disorder and tic disorders in childhood. Lancet. 1999; 354(9185):1153-1158.
125. Nicolson R, Swedo SE, Lenane M, et al. An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without poststreptococcal exacerbations. J Am Acad Child Adolesc Psychiatry. 2000;39(10):1313-1315.
126. Heubi C, Shott SR. PANDAS: pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections; an uncommon, but important indication for tonsillectomy. Int J Pediatr Otorhinolaryngol. 2003;67(8):837-840.
127. Batuecas Caletrio A, Sanchez Gonzalez F, Santa Cruz Ruiz S, Santos Gorjon P, Blanco Perez P. PANDAS syndrome: a new tonsillectomy indication? Acta Otorrinolaringol Esp. 2008;59(7):362-363. Spanish.
128. Coffey B, Wieland N. Tics, anxiety, and possible PANDAS in an adolescent. J Child Adolesc Psychopharmacol. 2007;17(4):533-538.
129. Chadehumbe MA, Greydanus DE, Feucht C, Patel DR. Psychopharmacology of tic disorders in children and adolescents. Pediatr Clin North Am. 2011;58(1):259-272, xiii.
130. Flessner CA. Cognitive-behavioral therapy for childhood repetitive behavior disorders: tic disorders and trichotillomania. Child Adolesc Psychiatr Clin N Am. 2011;20(2):319-328.
131. Storch EA, Murphy TK, Geffken GR, et al. Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: findings from a preliminary waitlist controlled open trial. J Am Acad Child Adolesc Psychiatry. 2006;45(10):1171-1178.
132. Hamlen RA, Kliman DS. Pediatric Lyme disease: a school issue; tips for school nurses. NASN Sch Nurse. 2009;24(3):114-115, 118.
133. Pavone P, Bianchini R, Parano E, et al. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol. 2004;30(2):107-110.
134. Snider LA, Sachdev V, MaCkaronis JE, St Peter M, Swedo SE. Echocardiographic findings in the PANDAS subgroup. Pediatrics. 2004;114(6):e748-e751.
135. Edwards MJ, Dale RC, Church AJ, et al. Adult-onset tic disorder, motor stereotypies, and behavioural disturbance associated with antibasal ganglia antibodies. Mov Disord. 2004;19(10):1190-1196.
136. Lewin AB, Storch EA, Murphy TK. Pediatric autoimmune neuropsychiatric disorders associated with streptococcus in identical siblings. J Child Adolesc Psychopharmacol. 2011;21(2):177-182.
137. Ercan TE, Ercan G, Severge B, Arpaozu M, Karasu G. Mycoplasma pneumoniae infection and obsessive-compulsive disease: a case report. J Child Neurol. 2008;23(3):338-340.
138. Termine C, Uggetti C, Veggiotti P, et al. Long-term follow-up of an adolescent who had bilateral striatal necrosis secondary to Mycoplasma pneumoniae infection. Brain Dev. 2005;27(1):62-65.
139. Muller N, Riedel M, Forderreuther S, Blendinger C, Abele-Horn M. Tourette's syndrome and Mycoplasma pneumoniae infection. Am J Psychiatry. 2000;157(3):481-482.
140. Wolff K, Johnson RA. Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology. 6th ed. New York (NY): McGraw-Hill Professional; 2009.
141. Goldberg EM, Rotondo KM. Complete antrioventricular block due to Lyme reinfection in a six year-old boy. Med Health R I. 2010;93(5): 158-160.
142. Perry CB. Erythema marginatum (rheumaticum). Arch Dis Child. 1937;12(70):233-238.
143. Frank DB, Patel AR, Sanchez GR, Shah MJ, Bonney WJ. Junctional tachycardia in a child with Lyme carditis. Pediatr Cardiol. 2011;32(5): 689-691.
144. Lo R, Menzies DJ, Archer H, Cohen TJ. Complete heart block due to lyme carditis. J Invasive Cardiol. 2003;15(6):367-369.
145. McAlister HF, Klementowicz PT, Andrews C, Fisher JD, Feld M, Furman S. Lyme carditis: an important cause of reversible heart block. Ann Intern Med. 1989;110(5):339-345.
146. Alto WA, Gibson R. Acute rheumatic fever: an update. Am Fam Physician. 1992;45(2):613-620.
147. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. Guidelines for the diagnosis of rheumatic fever: Jones Criteria, 1992 update. JAMA. 1992;268(15):2069-2073.
148. Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA. Erythema chronicum migrans and Lyme arthritis: the enlarging clinical spectrum. Ann Intern Med. 1977;86(6):685-698.
149. Szer IS, Taylor E, Steere AC. The long-term course of Lyme arthritis in children. N Engl J Med. 1991;325(3):159-163.
150. Glynn MW, Elmer BM, Garay PA, et al. MHCI negatively regulates synapse density during the establishment of cortical connections. Nat Neurosci. 2011;14(4):442-451.
151. Xia D, Shen K, Zhong W, Pan H. Administration of minocycline ameliorates damage in a renal ischemia/reperfusion injury model. Clin Invest Med. 2011;34(2):E55.
152. Sinha-Hikim I, Shen R, Nzenwa I, Gelfand R, Mahata SK, Sinha-Hikim AP. Minocycline suppresses oxidative stress and attenuates fet al cardiac myocyte apoptosis triggered by in utero cocaine exposure. Apoptosis. 2011;16(6):563-573.
153. Dumont EA, Lutgens SP, Reutelingsperger CP, Bos GM, Hofstra L. Minocycline inhibits apoptotic cell death in a murine model of partial flap loss. J Reconstr Microsurg. 2010;26(8):523-528.
154. Kernt M, Neubauer AS, Eibl KH, et al. Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2. Clin Ophthalmol. 2010;4:591-604.
155. Kernt M, Hirneiss C, Neubauer AS, Kampik A. Minocycline is cytoprotective in human corneal endothelial cells and induces anti-apoptotic B-cell CLL/lymphoma 2 (Bcl-2) and X-linked inhibitor of apoptosis (XIAP). Br J Ophthalmol. 2010;94(7):940-946.
156. Griffin MO, Ceballos G, Villarreal FJ. Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action. Pharmacol Res. 2011;63(2):102-107.
157. Yang L, Kim JH, Kovacs KD, Arroyo JG, Chen DF. Minocycline inhibition of photoreceptor degeneration. Arch Ophthalmol. 2009;127(11):1475-1480.
158. Kim HS, Suh YH. Minocycline and neurodegenerative diseases. Behav Brain Res. 2009;196(2):168-179.
159. Kikuchi K, Kawahara K, Biswas KK, et al. Minocycline attenuates both OGD-induced HMGB1 release and HMGB1-induced cell death in ischemic neuronal injury in PC12 cells. Biochem Biophys Res Commun. 2009;385(2):132-136.
160. Levkovitz Y, Mendlovich S, Riwkes S, et al. A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry. 2010; 71(2):138-149.
161. Miyaoka T. Clinical potential of minocycline for schizophrenia. CNS Neurol Disord Drug Targets. 2008;7(4):376-381.
162. Miyaoka T, Yasukawa R, Yasuda H, Hayashida M, Inagaki T, Horiguchi J. Minocycline as adjunctive therapy for schizophrenia: an open-label study. Clin Neuropharmacol. 2008;31(5):287-292.
163. Fritzsche M. Seasonal correlation of sporadic schizophrenia to Ixodes ticks and Lyme borreliosis. Int J Health Geogr. 2002;1(1):2.
164. Fritzsche M, Schmidli J. Seasonal fluctuation in schizophrenia. Am J Psychiatry. 2002;159(3):499-500.
165. Cannon M. Minocycline (Minocin). Atlanta, GA: American College of Rheumatology; 2010 [updated Sep 2009]. Available from: http://www. rheumatology.org/practice/clinical/patients/medications/minocycline. asp. Accessed September 21, 2011.
166. Steere AC, Angelis SM. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum. 2006;54(10):3079-3086.
167. Stricker RB, Johnson L. Searching for autoimmunity in " antibiotic-refractory" Lyme arthritis. Mol Immunol. 2008;45(11): 3023-3024.
168. Lettau LA. From the centers for fatigue control (CFC) weekly report: Lime disease; United States. Ann Intern Med. 1991;114:602.